WEEK # | TOPICS | READINGS |
---|---|---|
1 |
Introduction | [No readings] |
2 |
p53 first described |
Paper 1Lane, D. P., and L. V. Crawford. "T Antigen is Bound to a Host Protein in SV40-Transformed Cells." Nature 278 (1979): 261–3. Paper 2Linzer, D. I., and A. J. Levine. "Characterization of a 54K Dalton Cellular SV40 Tumor Antigen present in SV40-Transformed Cells and Uninfected Embryonal Carcinoma Cells." Cell 17, 43–52. |
3 |
An oncogene turned out to be a tumor suppressor |
Paper 1Eliyahu, D., D. Michalovitz, and M. Oren. "Overproduction of p53 Antigen Makes Established Cells Highly Tumorigenic." Nature 316 (1985): 158–60. Paper 2Finlay, C. A., P. W. Hinds, and A. J. Levine. "The p53 Proto-Oncogene Can Act as a Suppressor of Transformation." Cell 57 (1989): 1083–93. |
4 |
p53 mutation in cancer |
Paper 1Srivastava, S., Z. Q. Zou, K. Pirollo, W. Blattner, and E. H. Chang. "Germ-line Transmission of a Mutated p53 Gene in a Cancer-Prone Family with Li-Fraumeni Syndrome." Nature 348 (1990): 747–9. Paper 2Baker, S. J., E. R. Fearon, J. M. Nigro, S. R. Hamilton, A. C. Preisinger, J. M. Jessup, P. vanTuinen, D. H. Ledbetter, D. F. Barker, Y. Nakamura, R. White, and B. Vogelstein. "Chromosome 17 Deletions And p53 Gene Mutations in Colorectal Carcinomas." Science 244 (1989): 217–21. |
5 |
p53 and cancer mouse models |
Paper 1Donehower, L. A., M. Harvey, B. L. Slagle, M. J. McArthur, C. A. Montgomery, J. S. Butel, and A. Bradley. "Mice Deficient for p53 are Developmentally Normal but Susceptible to Spontaneous Tumours." Nature 356 (1992): 215–21. Paper 2Jacks, T., L. Remington, B. O. Williams, E. M. Schmitt, S. Halachmi, R. T. Bronson, and R. A. Weinberg. "Tumor Spectrum analysis in p53-Mutant Mice." Curr Biol 4 (1994): 1-7. |
6 |
p53 and programmed cell death (apoptosis) |
Paper 1Yonish-Rouach, E., D. Resnitzky, J. Lotem, L. Sachs, A. Kimchi, and M. Oren. "Wild-Type p53 Induces Apoptosis of Myeloid Leukaemic Cells that is Inhibited by Interleukin-6." Nature 352 (1991): 345–7. Paper 2Shaw, P., R. Bovey, S. Tardy, R. Sahli, B. Sordat, and J. Costa. "Induction of Apoptosis by Wild-Type p53 in a Human Colon Tumor-Derived Cell Line." Proc Natl Acad Sci USA 89 (1992): 4495–9. |
7 |
p53 and cell cycle regulation |
Paper 1Michalovitz, D., O. Halevy, and M. Oren. "Conditional Inhibition of Transformation and of Cell Proliferation by a Temperature-Sensitive Mutant of p53." Cell 62 (1990): 671–80. Paper 2el-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and B. Vogelstein. "WAF1, a Potential Mediator of p53 Tumor Suppression." Cell 75 (1993): 817–25. |
8 |
p53, DNA damage and genome integrity |
Paper 1Livingstone, L. R., A. White, J. Sprouse, E. Livanos, T. Jacks, and T. D. Tlsty. "Altered Cell Cycle Arrest and Gene Amplification Potential Accompany Loss of Wildtype p53." Cell 70 (1992): 923–35. Paper 2Kastan, M. B., O. Onyekwere, D. Sidransky, B. Vogelstein, and R. W. Craig. "Participation of p53 Protein in the Cellular Response to DNA Damage." Cancer Res 51 (1991): 6304–11. |
9 |
Field Trip | [No Readings] |
10 |
p53 and Mdm2 |
Paper 1Momand, J., G. P. Zambetti, D. C. Olson, D. George, and A. J. Levine. "The Mdm-2 Oncogene Product Forms a Complex with the p53 Protein and Inhibits p53-Mediated Transactivation." Cell 69 (1992): 1237–45. Paper 2Wu, X., J. H. Bayle, D. Olson, and A. J. Levine. "The p53-Mdm-2 Autoregulatory Feedback Loop." Genes Dev 7 (1993): 1126–32. |
11 |
p53 and microRNA |
Paper 1He, L., X. He, L. P. Lim, E. de Stanchina, Z. Xuan, Y. Liang, W. Zender, J. Magnus, D. Ridzon, A. L. Jackson, P. S. Linsley, C. Chen, S. W. Lowe, M. A. Cleary, and G. J. Hannon. "A microRNA Component of the p53 Tumour Suppressor Network." Nature 447 (2007): 1130–34. Paper 2Chang, T. C., E. A. Wentzel, O. A. Kent, K. Ramachandran, M. Mullendore, K. H. Lee, G. Feldmann, M. Yamakuchi, M. Ferlito, C. J. Lowenstein, D. E. Arking, M. A. Beer, A. Maitra, and J. T. Mendell. "Transactivation of miR-34a by p53 Broadly Influences Gene Expression and Promotes Apoptosis." Mol Cell 26 (2007): 745–52. |
12 |
p53 restoration therapy |
Paper 1Bykov, V. J., N. Issaeva, A. Shilov, M. Hultcrantz, E. Pugacheva, P. Chumakov, J. Bergman, K. G. Wiman, and G. Selivanova. "Restoration of the Tumor Suppressor Function to Mutant p53 by a Low-Molecular-Weight Compound." Nat Med 8 (2002): 282-8. Paper 2Martins, C. P., L. Brown-Swigart, and G. I. Evan. "Modeling the Therapeutic Efficacy of p53 Restoration in Tumors." Cell 127 (2006): 1323-34. |
13 |
Final class | [No readings] |